Brensocatib Could Change the Landscape of Bronchiectasis Treatment: James Chalmers, MD

Brensocatib Could Change the Landscape of Bronchiectasis Treatment: James Chalmers, MD

The landscape of treatment for bronchiectasis could change significantly with the approval of brensocatib, offering a more direct method of stemming the adverse events related to the condition, explains James Chalmers, MD, University of Dundee.

Metagenomic Profiling Maps Europe-Wide Bronchiectasis Resistomes

Next-generation metagenomic sequencing has uncovered key differences in bronchiectasis pathogens and resistance genes across Europe.